O. Yu. Goncharov
Research Subjects
O. Yu. Goncharov has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Olga Mikhailovna Kanunnikova
Russian Academy of Sciences
6 shared publications - Evgeny Krupitsky
Saint Petersburg First Pavlov State Medical University, Saint Petersburg 197022, Russia; V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Saint Petersburg 192019, Russia
5 shared publications - Ksenia V. Rybakova
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
5 shared publications V. I. Lad’YAnov
Physicotechnical Institute, Udmurt Federal Research Center, Ural Branch, Russian Academy of Sciences
4 shared publicationsA. I. Vyazova
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
3 shared publications- Anna A. Berezina
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
3 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 60 (5) , 57-69
Double-blind randomized placebo-controlled trial of the efficacy and safety of Agomelatin for alcohol dependence with comorbid depression
Background. Comorbidity of alcohol use disorder (AUD) with mental disorders is highly prevalent: depression, anhedonia, and sleep disturbances increase the risk of relapse. Aim: To study the efficacy and tolerability of agomelatine in the treatment of AUD with comorbid depression. Methods. A 26-week double-blind, randomized, placebo-controlled trial enrolled 100 patients with AUD and depression. The agomelatine group (AG, n = 50) received agomelatine 25 mg/night, while the placebo group (PG, n = 50) received placebo. Patients of both groups received weekly addiction counseling. Weekly assessments included: retrospective alcohol consumption monitoring, assessment of alcohol craving, depression, anhedonia, and subjective and objective sleep parameters. Results. Kaplan–Meier survival analysis showed significantly higher retention rates in the AG compared to the PG (12,34 weeks, 95% CI: 11,48–13,20 vs. 8,14 weeks, 95% CI: 7,01–9,27, p < 0.001). In the AG, mean daily alcohol consumption was significantly lower (F = 16,37, p < 0.001), and the number of heavy drinking days was fewer (0,14 ± 0,48 vs. 0,26 ± 0,64, F = 8,11, p = 0,004). The AG showed significantly greater reductions in alcohol craving by the Penn Alcohol Craving Scale, ObsessiveCompulsive Drinking Scale, and Visual Analogue Scale (1,83 ± 3,15 vs. 9,68 ± 3,78, F = 1866,7; 4,21 ± 7,80 vs. 22,65 ± 9,75, F = 1259,3; 6.93 ± 11,56 vs. 45,49 ± 25,16, F = 2267,0; all p Conclusion. Agomelatine 25 mg/day is an effective treatment for alcohol use disorder with comorbid depression.
- 31 October 2026
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 60 (5) , 57-69
Open AccessDouble-blind randomized placebo-controlled trial of the efficacy and safety of Agomelatin for alcohol dependence with comorbid depression
Background. Comorbidity of alcohol use disorder (AUD) with mental disorders is highly prevalent: depression, anhedonia, and sleep disturbances increase the risk of relapse. Aim: To study the efficacy and tolerability of agomelatine in the treatment of AUD with comorbid depression. Methods. A 26-week double-blind, randomized, placebo-controlled trial enrolled 100 patients with AUD and depression. The agomelatine group (AG, n = 50) received agomelatine 25 mg/night, while the placebo group (PG, n = 50) received placebo. Patients of both groups received weekly addiction counseling. Weekly assessments included: retrospective alcohol consumption monitoring, assessment of alcohol craving, depression, anhedonia, and subjective and objective sleep parameters. Results. Kaplan–Meier survival analysis showed significantly higher retention rates in the AG compared to the PG (12,34 weeks, 95% CI: 11,48–13,20 vs. 8,14 weeks, 95% CI: 7,01–9,27, p < 0.001). In the AG, mean daily alcohol consumption was significantly lower (F = 16,37, p < 0.001), and the number of heavy drinking days was fewer (0,14 ± 0,48 vs. 0,26 ± 0,64, F = 8,11, p = 0,004). The AG showed significantly greater reductions in alcohol craving by the Penn Alcohol Craving Scale, ObsessiveCompulsive Drinking Scale, and Visual Analogue Scale (1,83 ± 3,15 vs. 9,68 ± 3,78, F = 1866,7; 4,21 ± 7,80 vs. 22,65 ± 9,75, F = 1259,3; 6.93 ± 11,56 vs. 45,49 ± 25,16, F = 2267,0; all p Conclusion. Agomelatine 25 mg/day is an effective treatment for alcohol use disorder with comorbid depression.
- Open Access
Cognitive Factors of Remission in Alcohol Dependence with Comorbid Depression (a narrative review)
Objective. To analyze the cognitive factors of remission in alcohol dependence with comorbid recurrent depression, with an emphasis on data from systematic reviews and meta-analyses. Methods. A narrative synthesis of data from randomized controlled trials, cohort and observational studies, systematic reviews, and meta-analyses published between 2000 and 2026. Searches were conducted in PubMed, Web of Science, Scopus. Results. The results of studies characterizing the degree and structure of cognitive deficits, as well as their psychological and neurophysiological mechanisms in the context of remission formation, are summarized. Conclusion. Promising directions for further research and the potential application of the obtained data in the development of individualized treatment are outlined.
Open AccessCognitive Factors of Remission in Alcohol Dependence with Comorbid Depression (a narrative review)
Objective. To analyze the cognitive factors of remission in alcohol dependence with comorbid recurrent depression, with an emphasis on data from systematic reviews and meta-analyses. Methods. A narrative synthesis of data from randomized controlled trials, cohort and observational studies, systematic reviews, and meta-analyses published between 2000 and 2026. Searches were conducted in PubMed, Web of Science, Scopus. Results. The results of studies characterizing the degree and structure of cognitive deficits, as well as their psychological and neurophysiological mechanisms in the context of remission formation, are summarized. Conclusion. Promising directions for further research and the potential application of the obtained data in the development of individualized treatment are outlined.
- Open Access
- 10 January 2026
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 59 (4-2) , 109-119
Assessment of the relationship between anhedonia, sleep quality and alcohol craving in patients with alcohol dependence and comorbid depression
Оценка взаимосвязи ангедонии, качества сна и влечения к алкоголю у пациентов с алкогольной зависимостью и коморбидной депрессией
- 10 January 2026
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 59 (4-2) , 109-119
Open AccessAssessment of the relationship between anhedonia, sleep quality and alcohol craving in patients with alcohol dependence and comorbid depression
Оценка взаимосвязи ангедонии, качества сна и влечения к алкоголю у пациентов с алкогольной зависимостью и коморбидной депрессией
- Open Access
- 7 July 2022
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 20 (2) , 68-78
Sleep Disturbances in Patients with Alcohol Dependence with and without Tobacco Use
Нарушения сна у курящих и некурящих пациентов с синдромом зависимости от алкоголя
- 7 July 2022
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 20 (2) , 68-78
Open AccessSleep Disturbances in Patients with Alcohol Dependence with and without Tobacco Use
Нарушения сна у курящих и некурящих пациентов с синдромом зависимости от алкоголя
- 1 May 2021
- Published by Pleiades Publishing Ltd in Inorganic Materials: Applied Research
- Vol. 12 (3) , 731-734
Analysis of Layer Composition Formed on Stainless Steel Substrates upon Chemical Vapor Deposition of Tantalum
This article discusses interaction between reagents and stainless steel substrate upon deposition of tantalum coating by reduction of tantalum bromide with cadmium. It has been established that, at deposition temperatures higher than 1000 K, iron and chromium in stainless steel will reduce tantalum pentabromide, transferring into the gas phase in the form of bromides. As a consequence, not only tantalum bromide is reduced on the substrate but also iron bromide, which leads to formation of sublayer containing iron in the coating. An increase in the surface area of stainless steel interacting with reagents leads to an increase in the content of iron bromide, and in this case, the coating is formed from the mixture of Ta + Fe2Ta. In addition, chromium bromide is formed on the substrate, which is removed together with other reaction products, resulting in depletion of chromium in steel surface layers.
- 1 May 2021
- Published by Pleiades Publishing Ltd in Inorganic Materials: Applied Research
- Vol. 12 (3) , 731-734
Analysis of Layer Composition Formed on Stainless Steel Substrates upon Chemical Vapor Deposition of Tantalum
This article discusses interaction between reagents and stainless steel substrate upon deposition of tantalum coating by reduction of tantalum bromide with cadmium. It has been established that, at deposition temperatures higher than 1000 K, iron and chromium in stainless steel will reduce tantalum pentabromide, transferring into the gas phase in the form of bromides. As a consequence, not only tantalum bromide is reduced on the substrate but also iron bromide, which leads to formation of sublayer containing iron in the coating. An increase in the surface area of stainless steel interacting with reagents leads to an increase in the content of iron bromide, and in this case, the coating is formed from the mixture of Ta + Fe2Ta. In addition, chromium bromide is formed on the substrate, which is removed together with other reaction products, resulting in depletion of chromium in steel surface layers.
- Open Access
- 14 January 2020
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 18 (4) , 26-35-35
The prevalence of the sleep disturbances among the patients with substance use disorders
Background. There is evidence that sleep disorders may be significantly linked to the development of the substance use disorders (SUD). However, data about the prevalence of the sleep disturbances among patients with SUD in Russia are relatively limited.Aim. To evaluate the frequency of the sleep disturbances among patients (n = 196) with alcohol (ÀD, n = 102), opioid (ÎD, n = 55) and polysubstance dependence (PD, n = 39) seeking addiction medical care.Materials and methods. We conduct a cross-sectional study of sleep disturbances among patients in St. Petersburg in 2017–2018. The modified Insomnia Severity Index (ISI) was administered to assess sleep during different periods of time: lifetime, the past 12 months, and the past 30 days.Results. All groups demonstrated relatively high presence of different sleep disorders (range: 49.0–76.5% among 196). The sleep disturbances over the past 30 days were more common in the AD group (60.8– 73.5% among 102) with the early morning awakening as the most frequent complaint. In the PD group the prevalence of lifetime sleep disturbances was high (94.9–100.0% among 39), whereas insomnia disorders were relatively rare over the past 30 days. However, it was sleep disturbances over the past 30 days that were statistically significantly more often (p < 0,05) observed in the group of patients who actively consume narcotic substances (40.2–87.2%), compared with the group of patients in remission (0–16.7%).Conclusion. The results demonstrated the high prevalence of insomnia among patients with SUD and suggested that the remission have a positive effect on the symptoms of sleep disorders. Further studies of the association between sleep disturbances and SUD progression are needed.
- 14 January 2020
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 18 (4) , 26-35-35
Open AccessThe prevalence of the sleep disturbances among the patients with substance use disorders
Background. There is evidence that sleep disorders may be significantly linked to the development of the substance use disorders (SUD). However, data about the prevalence of the sleep disturbances among patients with SUD in Russia are relatively limited.Aim. To evaluate the frequency of the sleep disturbances among patients (n = 196) with alcohol (ÀD, n = 102), opioid (ÎD, n = 55) and polysubstance dependence (PD, n = 39) seeking addiction medical care.Materials and methods. We conduct a cross-sectional study of sleep disturbances among patients in St. Petersburg in 2017–2018. The modified Insomnia Severity Index (ISI) was administered to assess sleep during different periods of time: lifetime, the past 12 months, and the past 30 days.Results. All groups demonstrated relatively high presence of different sleep disorders (range: 49.0–76.5% among 196). The sleep disturbances over the past 30 days were more common in the AD group (60.8– 73.5% among 102) with the early morning awakening as the most frequent complaint. In the PD group the prevalence of lifetime sleep disturbances was high (94.9–100.0% among 39), whereas insomnia disorders were relatively rare over the past 30 days. However, it was sleep disturbances over the past 30 days that were statistically significantly more often (p < 0,05) observed in the group of patients who actively consume narcotic substances (40.2–87.2%), compared with the group of patients in remission (0–16.7%).Conclusion. The results demonstrated the high prevalence of insomnia among patients with SUD and suggested that the remission have a positive effect on the symptoms of sleep disorders. Further studies of the association between sleep disturbances and SUD progression are needed.
- 1 February 2019
- Published by Pleiades Publishing Ltd in Russian Journal of Physical Chemistry A
- Vol. 93 (2) , 343-348
Formation of Surface Layers on Fe70Si15B15 Alloy upon Heating in an Inert Atmosphere with Air Impurities
The composition of surface layers formed during high-temperature interaction between Fe70Si15B15alloy and air impurities in an inert atmosphere is determined using equilibrium thermodynamic...
- 1 February 2019
- Published by Pleiades Publishing Ltd in Russian Journal of Physical Chemistry A
- Vol. 93 (2) , 343-348
Formation of Surface Layers on Fe70Si15B15 Alloy upon Heating in an Inert Atmosphere with Air Impurities
The composition of surface layers formed during high-temperature interaction between Fe70Si15B15alloy and air impurities in an inert atmosphere is determined using equilibrium thermodynamic...
- Open Access
- 1 January 2019
- Published by Institute for Metals Superplasticity Problems of RAS in Letters on Materials
- Vol. 9 (1) , 22-26
Influence of deposition conditions on the composition of tantalum coatings
In this paper, tantalum coatings obtained by the chemical vapour deposition in reactors with “hot” and “cold” walls were analyzed.
- 1 January 2019
- Published by Institute for Metals Superplasticity Problems of RAS in Letters on Materials
- Vol. 9 (1) , 22-26
Open AccessInfluence of deposition conditions on the composition of tantalum coatings
In this paper, tantalum coatings obtained by the chemical vapour deposition in reactors with “hot” and “cold” walls were analyzed.
- 14 September 2017
- Published by Pleiades Publishing Ltd in Inorganic Materials
- Vol. 53 (10) , 1064-1068
Tantalum chemical vapor deposition on substrates from various materials
Tantalum coatings have been produced for the first time by hydrogen-free chemical vapor deposition through reduction of tantalum pentabromide with cadmium vapor, which allowed the deposition temperature to be substantially reduced (by more than 200 K). The coatings consisted of α- and/or β-Ta, depending on the substrate material.
- 14 September 2017
- Published by Pleiades Publishing Ltd in Inorganic Materials
- Vol. 53 (10) , 1064-1068
Tantalum chemical vapor deposition on substrates from various materials
Tantalum coatings have been produced for the first time by hydrogen-free chemical vapor deposition through reduction of tantalum pentabromide with cadmium vapor, which allowed the deposition temperature to be substantially reduced (by more than 200 K). The coatings consisted of α- and/or β-Ta, depending on the substrate material.
- 31 August 2017
- Published by World Scientific Pub Co Pte Ltd in Journal of Theoretical and Computational Chemistry
- Vol. 16 (06)
Correlation model to estimate the thermodynamic properties
A technique for constructing the correlation dependencies of the thermodynamic properties of similar compounds was proposed. This technique is based on the Taylor expansion in the supposed analytic relationship between properties. The constructed correlation dependencies were used to estimate the thermodynamic properties of the condensed bromides and iodides of hafnium HfGn (G [Formula: see text] Br, I and [Formula: see text], 2, 3, 4) and the compounds formed in the PbO–SiO2 system. Standard formation enthalpy [Formula: see text], entropy [Formula: see text], heat capacity [Formula: see text] and temperature dependencies [Formula: see text] at temperatures T[Formula: see text][Formula: see text]k to 3000[Formula: see text]k were estimated. The standard estimation error of the thermodynamic properties of the compounds in the PbO–SiO2 system does not exceed 2% for all the estimated properties. For condensed halides, the standard estimation error was (1) [Formula: see text]% for enthalpy, (2) [Formula: see text]% for entropy, (3) [Formula: see text]% for heat capacity.
- 31 August 2017
- Published by World Scientific Pub Co Pte Ltd in Journal of Theoretical and Computational Chemistry
- Vol. 16 (06)
Correlation model to estimate the thermodynamic properties
A technique for constructing the correlation dependencies of the thermodynamic properties of similar compounds was proposed. This technique is based on the Taylor expansion in the supposed analytic relationship between properties. The constructed correlation dependencies were used to estimate the thermodynamic properties of the condensed bromides and iodides of hafnium HfGn (G [Formula: see text] Br, I and [Formula: see text], 2, 3, 4) and the compounds formed in the PbO–SiO2 system. Standard formation enthalpy [Formula: see text], entropy [Formula: see text], heat capacity [Formula: see text] and temperature dependencies [Formula: see text] at temperatures T[Formula: see text][Formula: see text]k to 3000[Formula: see text]k were estimated. The standard estimation error of the thermodynamic properties of the compounds in the PbO–SiO2 system does not exceed 2% for all the estimated properties. For condensed halides, the standard estimation error was (1) [Formula: see text]% for enthalpy, (2) [Formula: see text]% for entropy, (3) [Formula: see text]% for heat capacity.